Using enhanced precautions to prevent the spread of antibiotic-resistant bacteria in nursing homes
Official title: Optimal Use of Enhanced Barrier Precautions in Nursing Homes to Prevent the Transmission of MDROs
Funded at University of Maryland Baltimore · NIH-11037234 · Data updated 2026-11-12
This study is looking at how wearing gowns and gloves can help keep nursing home residents safe from germs that are hard to treat, especially for those with chronic wounds or on ventilators, so that staff can focus on the residents who need the most protection without making their jobs harder.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Maryland Baltimore NIH-funded |
| Lab location | 1 site (Baltimore, United States) |
| Project start | December 15, 2024 |
| Project end | November 30, 2026 |
| Funding year | 2025 |
| Award (this year) | $427,625 |
| NIH project number | 1R21AG091717-01 |
| Project ID | NIH-11037234 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are nursing home residents, particularly those with chronic ventilatory support or a history of MDRO colonization.
✕Less likely to help
Patients who do not reside in nursing homes or those without chronic conditions requiring enhanced precautions may not benefit from this research.
What this research studies
This research investigates the use of enhanced barrier precautions (EBP) in nursing homes to prevent the transmission of multi-drug resistant organisms (MDROs). It focuses on the application of gowns and gloves during high-contact care activities for residents, particularly those with chronic wounds or devices. The study aims to better identify which residents are at the highest risk for MDRO transmission, especially chronic ventilator residents, to optimize the use of EBP and reduce unnecessary burdens on nursing home staff. By analyzing contamination levels on healthcare provider attire, the research seeks to refine guidelines for EBP implementation.
Why it matters
Potential benefit: If successful, this research could significantly reduce the transmission of antibiotic-resistant infections in nursing homes, improving patient safety and health outcomes.
How similar studies have gone: Previous research has shown that enhanced precautions can effectively reduce infection rates in healthcare settings, suggesting potential success for this approach in nursing homes.
Where this research is happening
-
University of Maryland Baltimore
Baltimore, United States Active
Researchers
- Principal investigator: Roghmann, Mary-Claire — University of Maryland Baltimore
- Study coordinator: Roghmann, Mary-Claire
Related research
Other NIH-funded projects on the same topics.
-
Resilient HIV Implementation for LGBTQ Youth in Africa and Beyond
A program to help young people ages 15–24 who are at risk for or living with HIV, especially sexual and gender minority youths, access better HIV prevention and care through real-world health practice improvements.
-
Algorithms to find HLA-E neoantigens for cancer immunotherapy
Aims to develop computer methods to discover tumor-specific targets presented by HLA-E to guide new T cell therapies for cancer.
-
NPRL2 loss and focal cortical dysplasia in epilepsy
This grant investigates how losing NPRL2 in the brain contributes to focal cortical dysplasia and epilepsy in children.
-
New way to make head and neck cancer treatments work better
A research project at the University of Maryland Baltimore aims to improve treatment for advanced head and neck cancer, with a focus on making cisplatin and newer therapies work better while reducing kidney side effects.
-
Genetics and function of inherited brain disorders that affect thinking and behavior
Scientists are studying how genes and cellular helpers shape brain development and why certain kids have intellectual disabilities and adaptive-behavior challenges.
-
Finding broadly protective antibodies against Crimean-Congo Hemorrhagic Fever
Researchers will study blood from people who survived CCHF to find human antibodies that protect against multiple virus variants, with early tests in animal models to check their breadth.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.